HQL · abrdn Life Sciences Investors

$19.34 -0.03 (-0.15%)

Market Cap

$589.00M

30.41M

Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.

abrdn Life Sciences Investors

Reported 2026-03-31

Net Assets

$560,827,555

Total Assets

$561,849,915

Holdings

143

Filed

2026-05-29

Holding	CUSIP	Balance	Units	Value	% Net Assets	Category	Country
Insmed Inc	457669307	104,142	NS	$17,029,300	3.04%	EC	US
Vaxcyte Inc	92243G108	286,930	NS	$16,673,502	2.97%	EC	US
uniQure NV	000000000	972,920	NS	$15,907,242	2.84%	EC	NL
Argenx SE	04016X101	19,643	NS	$14,344,301	2.56%	EC	NL
Dyne Therapeutics Inc	26818M108	763,959	NS	$13,850,577	2.47%	EC	US
Denali Therapeutics Inc	24823R105	664,716	NS	$12,762,547	2.28%	EC	US
Axsome Therapeutics Inc	05464T104	73,746	NS	$12,464,549	2.22%	EC	US
Xenon Pharmaceuticals Inc	98420N105	202,664	NS	$11,784,912	2.10%	EC	CA
Fulcrum Therapeutics Inc	359616109	1,518,506	NS	$11,646,941	2.08%	EC	US
Tectonic Therapeutic Inc	878972108	370,884	NS	$11,464,024	2.04%	EC	US
NEUROVANCE MILESTONE INTEREST	000000000	34,055	NS	$11,457,801	2.04%	EC	US
Crinetics Pharmaceuticals Inc	22663K107	312,153	NS	$11,337,397	2.02%	EC	US
Edgewise Therapeutics Inc	28036F105	353,076	NS	$11,121,894	1.98%	EC	US
Immunovant Inc	45258J102	441,498	NS	$10,966,810	1.96%	EC	US
Alnylam Pharmaceuticals Inc	02043Q107	30,216	NS	$9,997,568	1.78%	EC	US
Cytokinetics Inc	23282W605	150,025	NS	$9,888,148	1.76%	EC	US
VeraDermics Inc	922967104	155,623	NS	$9,827,592	1.75%	EC	US
Regeneron Pharmaceuticals Inc	75886F107	12,398	NS	$9,579,191	1.71%	EC	US
BioCryst Pharmaceuticals Inc	09058V103	996,017	NS	$9,482,082	1.69%	EC	US
Personalis Inc	71535D106	1,430,790	NS	$9,114,132	1.63%	EC	US
Praxis Precision Medicines Inc	74006W207	28,244	NS	$9,099,934	1.62%	EC	US
Sarepta Therapeutics Inc	803607100	416,313	NS	$9,058,971	1.62%	EC	US
Arrowhead Pharmaceuticals Inc	04280A100	143,265	NS	$8,982,716	1.60%	EC	US
EyePoint Inc	30233G209	616,005	NS	$7,940,304	1.42%	EC	US
Shattuck Labs Inc	82024L103	1,159,321	NS	$7,454,434	1.33%	EC	US
Ideaya Biosciences Inc	45166A102	210,611	NS	$7,017,559	1.25%	EC	US
VERADERMICS, INC.	000000000	109,305	NS	$6,902,611	1.23%	EP	US
Oculis Holding AG	000000000	253,740	NS	$6,746,947	1.20%	EC	CH
Sionna Therapeutics Inc	829401108	168,051	NS	$6,737,165	1.20%	EC	US
Equillium Inc	29446K106	3,352,837	NS	$6,705,674	1.20%	EC	US
Syndax Pharmaceuticals Inc	87164F105	286,969	NS	$6,703,596	1.20%	EC	US
Amgen Inc	031162100	18,629	NS	$6,554,614	1.17%	EC	US
Biohaven Ltd	000000000	771,452	NS	$6,526,484	1.16%	EC	VG
Abivax SA	00370M103	58,444	NS	$6,507,739	1.16%	EC	FR
Apogee Therapeutics Inc	03770N101	76,841	NS	$6,467,707	1.15%	EC	US
Disc Medicine Inc	254604101	99,339	NS	$6,351,736	1.13%	EC	US
Travere Therapeutics Inc	89422G107	203,913	NS	$6,058,255	1.08%	EC	US
Precision BioSciences Inc	74019P207	1,085,970	NS	$5,972,835	1.07%	EC	US
Structure Therapeutics Inc	86366E106	119,693	NS	$5,769,203	1.03%	EC	KY
Nuvalent Inc	670703107	55,694	NS	$5,705,850	1.02%	EC	US
Adaptive Biotechnologies Corp	00650F109	394,969	NS	$5,482,170	0.98%	EC	US
ARS Pharmaceuticals Inc	82835W108	638,505	NS	$5,127,195	0.91%	EC	US
Corbus Pharmaceuticals Holdings Inc	21833P301	543,719	NS	$5,105,521	0.91%	EC	US
Newamsterdam Pharma Co NV	000000000	157,389	NS	$5,038,022	0.90%	EC	NL
Codexis Inc	192005106	3,090,272	NS	$5,037,143	0.90%	EC	US
IMMUNIC	000000000	4,444,604	NS	$4,933,510	0.88%	DE	US
Taysha Gene Therapies Inc	877619106	1,021,063	NS	$4,564,152	0.81%	EC	US
Summit Therapeutics Inc	86627T108	238,231	NS	$4,516,860	0.81%	EC	US
CURASEN THERAPEUTICS, INC.	000000000	9,049,182	NS	$4,339,083	0.77%	EP	US
Vertex Pharmaceuticals Inc	92532F100	9,163	NS	$4,091,646	0.73%	EC	US

Showing 1–50 of 143 holdings

Key facts CIK 884121 CUSIP 87911K100 13F (30d) 31 filings 31 filers